tiprankstipranks
Trending News
More News >
Chemipro Kasei Kaisya,Ltd. (JP:4960)
:4960
Japanese Market

Chemipro Kasei Kaisya,Ltd. (4960) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4960

Chemipro Kasei Kaisya,Ltd.

(4960)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 5.2)
,
Neutral 60 (OpenAI - 5.2)
,
Neutral 60 (OpenAI - 5.2)
,
Neutral 60 (OpenAI - 5.2)
,
Neutral 60 (OpenAI - 5.2)
,
Neutral 60 (OpenAI - 5.2)
,
Neutral 60 (OpenAI - 5.2)
,
Neutral 60 (OpenAI - 5.2)
Rating:60Neutral
Price Target:
¥716.00
▲(116.97% Upside)
Action:DowngradedDate:02/25/26
The score is primarily supported by solid financial performance, especially stable profitability and strong operating cash flow. This is tempered by a demanding valuation (very high P/E with a low dividend yield) and mixed technical signals indicating weaker near-term momentum.
Positive Factors
Operating cash flow strength
Consistent operating cash flow and a strong operating cash flow-to-net-income ratio indicate the business generates real cash from operations. That durability supports reinvestment in production, funds working capital needs, and reduces reliance on external financing across a multi-month horizon.
Margin sustainability
Stable gross margins coupled with a rising net profit margin reflect effective cost control and pricing power in core formulations. These margin dynamics underpin lasting profitability even if sales fluctuate, supporting operational resilience and cash conversion over several quarters.
Niche B2B specialty-chemicals model
A focused B2B specialty-chemicals business supplying additives and performance formulations creates durable customer relationships and technical differentiation. Supplying tailored intermediates to multiple end markets reduces commoditization risk and supports recurring revenue streams over time.
Negative Factors
Inconsistent revenue growth
Negative and uneven revenue growth indicates demand variability in downstream markets and creates uncertainty for scale-dependent margin improvements. Persistent top-line weakness can limit reinvestment capacity and magnify the impact of fixed costs over several quarters.
Elevated leverage
A relatively high debt-to-equity ratio raises refinancing and interest-rate sensitivity risk, reducing financial flexibility. In an industry with cyclical demand, elevated leverage can pressure liquidity and constrain strategic investments if cash flows soften over the medium term.
Free cash flow volatility
Although operating cash flow is strong, free cash flow growth has been volatile, signaling episodic capital spending or working-capital swings. This variability hampers predictable capital allocation, dividend consistency, and buffer capacity against cyclical downturns across months.

Chemipro Kasei Kaisya,Ltd. (4960) vs. iShares MSCI Japan ETF (EWJ)

Chemipro Kasei Kaisya,Ltd. Business Overview & Revenue Model

Company DescriptionChemipro Kasei Kaisha, Ltd. manufactures and sells chemicals and household products in Japan. The company offers chemicals, including UV absorbers, light stabilizers, antioxidants, organic electronic materials, intermediates for dyestuffs, and other products, such as color developer, corrosion inhibitors, and intermediates. It also provides ultraviolet absorbers, medical and agricultural chemical intermediates, electronic materials, etc. In addition, the company manufactures plastic additives. Further, it develops, manufactures, and sells wood preservatives, fungicides, and insecticides. Chemipro Kasei Kaisha, Ltd. was incorporated in 1949 and is based in Kobe, Japan.
How the Company Makes MoneyChemipro Kasei makes money primarily by selling specialty chemical products to business customers (B2B). Revenue is generated from (1) product sales of chemical additives and functional materials that are incorporated into customers’ manufacturing processes or finished goods, and (2) sales of related chemical intermediates/industrial chemicals where the company supplies specific formulations or compounds to meet customer specifications. Earnings are driven by shipment volumes and unit pricing, which depend on demand in downstream manufacturing markets, the company’s ability to maintain differentiated performance/quality, and its cost management for raw materials and production. Information on significant partnerships, customer concentration, licensing/royalty income, or segment-by-segment revenue breakdown is null.

Chemipro Kasei Kaisya,Ltd. Financial Statement Overview

Summary
Overall fundamentals are solid: stable margins and improving net profit margin support profitability, and operating cash flow is consistently strong. The main offset is mixed revenue trends and a relatively high debt-to-equity ratio that adds balance-sheet risk.
Income Statement
70
Positive
The company shows a stable gross profit margin and a slight increase in net profit margin, indicating efficient cost management. However, revenue growth has been inconsistent, particularly a decline from 2020 to 2021. EBIT and EBITDA margins show minor fluctuations, reflecting stability in core operations despite revenue challenges.
Balance Sheet
65
Positive
The debt-to-equity ratio is relatively high, suggesting significant leverage which could be a risk in a volatile market. The equity ratio is stable, indicating the company maintains a balanced asset base. Return on equity has been improving, showing increasing profitability relative to shareholder equity.
Cash Flow
75
Positive
The company demonstrates strong cash flow management with consistent operating cash flow, though free cash flow growth shows some volatility. The operating cash flow to net income ratio suggests robust cash earnings relative to reported profits, enhancing financial stability.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue9.71B9.24B9.76B9.74B9.55B
Gross Profit1.45B1.50B1.37B1.66B1.43B
EBITDA651.08M647.30M665.54M830.86M726.80M
Net Income128.08M126.17M71.08M179.17M180.16M
Balance Sheet
Total Assets13.35B13.79B13.85B13.52B13.70B
Cash, Cash Equivalents and Short-Term Investments2.15B1.88B956.72M1.91B2.14B
Total Debt5.55B6.18B6.08B5.95B6.91B
Total Liabilities8.58B9.11B9.26B8.94B9.18B
Stockholders Equity4.78B4.68B4.60B4.57B4.53B
Cash Flow
Free Cash Flow1.05B900.60M-924.38M856.60M267.90M
Operating Cash Flow1.26B1.18B-694.99M1.11B588.18M
Investing Cash Flow-288.57M-213.17M-230.97M-248.94M-222.80M
Financing Cash Flow-713.97M-43.94M-29.48M-1.08B-118.39M

Chemipro Kasei Kaisya,Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price330.00
Price Trends
50DMA
718.98
Negative
100DMA
526.15
Positive
200DMA
404.65
Positive
Market Momentum
MACD
-10.76
Positive
RSI
46.91
Neutral
STOCH
36.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4960, the sentiment is Neutral. The current price of 330 is below the 20-day moving average (MA) of 701.00, below the 50-day MA of 718.98, and below the 200-day MA of 404.65, indicating a neutral trend. The MACD of -10.76 indicates Positive momentum. The RSI at 46.91 is Neutral, neither overbought nor oversold. The STOCH value of 36.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4960.

Chemipro Kasei Kaisya,Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥15.97B8.023.89%-3.00%-29.83%
72
Outperform
¥9.08B23.472.97%9.92%-27.64%
71
Outperform
¥13.72B9.401.81%9.07%
69
Neutral
¥9.18B20.792.98%-9.60%-38.34%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
¥11.21B15.261.06%-9.63%-1.71%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4960
Chemipro Kasei Kaisya,Ltd.
682.00
339.53
99.14%
JP:4093
Toho Acetylene Co., Ltd.
457.00
100.15
28.07%
JP:4366
Daito Chemix Corporation
414.00
206.94
99.94%
JP:4531
Yuki Gosei Kogyo Co., Ltd.
416.00
146.06
54.11%
JP:6568
KNC Laboratories Co.,Ltd.
1,180.00
111.74
10.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 25, 2026